Community Research and Development Information Service - CORDIS

Results 1 - 10 of 63
Order by: Results/page:
12 3 4 5 6 7 > 
Cancer treatment and monitoring through identification of circulating tumour cells and tumour related nucleic acids in blood
ID: 115749
Start date: 2015-01-01, End date: 2019-12-31
Blood-based biomarkers such as Circulating Tumor Cells (CTCs), circulating free tumor DNA (cfDNA) and microRNAs (miRNAs) have the potential to improve the development of personalized medicines for cancer patients. This is of particular importance when biopsies of the primary ...
Programme: FP7-JTI
Record Number: 203725
Last updated on: 2017-04-24
Pre-normative research on resistance to mechanical impact of composite overwrapped pressure vessels
ID: 621194
Start date: 2014-04-01, End date: 2017-06-30
Hydrogen is expected to be a highly valuable energy carrier for the 21st century as it should participate in answering main societal and economical concerns. However, in order to enable its extensive use as an energy vector, it is of primary importance to ensure its societal ...
Programme: FP7-JTI
Record Number: 189875
Last updated on: 2017-04-17
Applied Public-Private Research enabling OsteoArthritis Clinical Headway
ID: 115770
Start date: 2015-06-01, End date: 2020-11-30
The problem: finding the right patient for the right treatment Despite a large and growing disease burden in osteoarthritis (OA), many pharmaceutical companies have de-emphasized or even abandoned OA drug development due to perceived hurdles. Crucial in this is the lack of ap...
Programme: FP7-JTI
Record Number: 203727
Last updated on: 2017-04-17
BeTheCuRE
[PROJECT] BTCURE - BeTheCuRE
ID: 115142
Start date: 2011-04-01, End date: 2017-03-31
BTCure is based on the recognition that RA is a heterogeneous disease where a major subset involves adaptive immunity, and that animal models have to develop the line with the different subsets of the human diseases in order to be optimally used for drug discovery and drug ev...
Programme: FP7-JTI
Record Number: 203688
Last updated on: 2017-04-17
Innovative SOFC Architecture based on Triode Operation
ID: 298300
Start date: 2012-09-01, End date: 2016-02-29
The development of Solid Oxide Fuel Cells (SOFCs) operating on hydrocarbon fuels (natural gas, biofuel,LPG) is the key to their short to medium term broad commercialization. The development of direct HC SOFCs still meets lot of challenges and problems arising from the fact th...
Programme: FP7-JTI
Record Number: 104881
Last updated on: 2017-04-10
Unbiased Biomarkers for the Prediction of Respiratory Disease Outcomes
ID: 115010
Start date: 2009-10-01, End date: 2015-09-30
Rationale The inability of pre-clinical studies to predict clinical efficacy is a major bottleneck in drug development. In severe asthma this bottleneck results from: a lack of useful and validated biomarkers, underperforming pre-clinical models, inadequate and incomplete sub...
Programme: FP7-JTI
Record Number: 203682
Last updated on: 2017-04-03
DRIVING RE-INVESTMENT IN R&D AND RESPONSIBLE ANTIBIOTIC USE
ID: 115618
Start date: 2014-10-01, End date: 2017-09-30
Antimicrobial resistance (AMR) is widespread. Its global human and economic burden is tremendous and increasing annually. Yet today only a few pharmaceutical companies retain active antibacterial drug discovery programmes. While the elaboration of antibiotics with novel mecha...
Programme: FP7-JTI
Record Number: 203717
Last updated on: 2017-03-06
Hydrogen Contaminant Risk Assessment
ID: 621223
Start date: 2014-04-01, End date: 2017-06-30
In HyCoRA project, a strategy for cost reduction for hydrogen fuel quality assurance QA is developed and executed. For developing this strategy, hydrogen quality risk assessment is used to define the needs for hydrogen impurity gas analysis, system level PEMFC contaminant res...
Programme: FP7-JTI
Record Number: 185720
Last updated on: 2017-02-27
Collaboration on the Optimisation of  Macromolecular Pharmaceutical Access to Cellular Targets
ID: 115363
Start date: 2012-11-01, End date: 2017-10-31
Most biopharmaceuticals (BP) currently on the market are recombinant proteins which are parenterally administered. These would benefit from more patient-friendly routes of administration. Moreover, new classes of BP (e.g. siRNA, miRNA, DARPins) with specificity for intracellu...
Programme: FP7-JTI
Record Number: 203704
Last updated on: 2017-02-21
ELECTRA
[PROJECT] ELECTRA - ELECTRA
ID: 621244
Start date: 2014-03-03, End date: 2017-03-02
High temperature electrolysers (HTEs) produce H2 efficiently utilising electricity from renewable sources and steam from solar, geothermal, or nuclear plants. CO2 can be co-electrolysed to produce syngas and fuels. The traditional solid oxide electrolyser cell (SOEC) leaves w...
Programme: FP7-JTI
Record Number: 185722
Last updated on: 2017-02-13
12 3 4 5 6 7 > 
List retrieved on: 2017-04-28
Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top